ASX announcement today. Note automatic needle safety device.4...

ASX announcement today. Note automatic needle safety device.
4 August 2011
Alchemia?s drug launched in US market
? Sales imminent
? European launch expected in 2012
Alchemia, Brisbane, Australia (ASX: ACL) is delighted to announce the launch of generic
fondaparinux sodium for injection, in the United States by its marketing partner Dr Reddy?s
Laboratories. (Dr Reddy?s). The launch follows the approval by the US Food and Drug
Administration of the Abbreviated New Drug Application (ANDA) received on 11 July 2011. The
launch covers 2.5mg/0.5 ml, 5.0mg/0.4 ml, 7.5mg/0.6 ml and 10.0mg?/0.8 ml doses of the drug in
prefilled colour coded, single-dose syringes with an automatic needle safety device.